@ChrisTheTwinDad @CQueenbeejdl @bfhermann @RyanMarino Yeah, but do you have any studies to support this? The quality of studies supporting amphetamines for ADHD regarding long term benefit appear poor. https://t.co/BilpUft6JP https://t.co/EfhOvfLurw
@Run_Fox_Run @DonnaKarnage @SNeurotypicals Cochrane Review: "we found low‐ to very low‐quality evidence suggesting that amphetamines reduced the severity of ADHD symptoms as rated by clinicians...& patients...Overall, the evidence generated by this rev
"We found no evidence that amphetamines improved ADHD symptom severity compared to other drug interventions." https://t.co/i46mZ8WroN
@sludge_girl 1. wikipedia cont. (2021) lisdexamfetamine [/chemistry/comparison/]. https://t.co/xwkRY0PKse 2. castells 𝘦𝘵 𝘢𝘭. (2018) amphetamines for attention deficit hyperactivity disorder (adhd) in adults. https://t.co/QHWsa6DodQ
Anfetaminas para el trastorno de déficit de atención e hiperactividad (TDAH) en adultos https://t.co/W4s8Dox37E
RT @47zSd5kzOPbxay5: 成人ADHD患者のアンフェタミン類による治療について（Xavier Castells et al. Cochrane Database Syst Rev. 2018、オープンアクセス） 背景：ADHDの治療薬としてアンフェタミン類が広く…
RT @47zSd5kzOPbxay5: 成人ADHD患者のアンフェタミン類による治療について（Xavier Castells et al. Cochrane Database Syst Rev. 2018、オープンアクセス） 背景：ADHDの治療薬としてアンフェタミン類が広く…
成人ADHD患者のアンフェタミン類による治療について（Xavier Castells et al. Cochrane Database Syst Rev. 2018、オープンアクセス） 背景：ADHDの治療薬としてアンフェタミン類が広く用いられているが、効能と安全性には不確実性が残っていることから、それらを検証したい。 https://t.co/mgpwgeh1N7
@unterhuber Zwar ist die Evidenz "low to very low" aber "it appears that short‐term treatment with amphetamines reduces the severity of ADHD symptoms". #EvidenceBasedMedicine https://t.co/kZsk1QYBn5
RS Cochrane: pruebas de baja calidad e improbable validez externa indican que las anfetaminas mejoran la gravedad de síntomas de #TADH pero no la retención de tratamiento https://t.co/YghVLUWxMy
5pm daily #takehomemessage: "Amphetamines improved the severity of #ADHD symptoms, as assessed by clinicians or patients, in the short term but did not improve retention to treatment." https://t.co/kgxqrRTeWu
Amphetamines for attention deficit hyperactivity disorder in adults. Cochrane review finds improvements for patients in the short term. #ADHD Read more here: https://t.co/4dUZbrvIvD https://t.co/y7v2Twjgz1
Amphétamines et #TDAH, la cochrane doute de la qualité des études https://t.co/Zt9XT4xtm0
"The short duration of studies coupled with their restrictive inclusion criteria limits the external validity of these findings...none of the included studies had an overall low risk of bias. Overall the evidence generated by this review is of low or very